Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, offering promising developments throughout several clinical and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, much more trustworthy option for therapeutic us